PreMarket Price
PreMarket Price
EarningsInternational Business Machines Corporation (IBM) reports in 5 days (2026-10-21, after market close).Full calendar →
International Business Machines Corporation (IBM) logo

Stock Analysis

International Business Machines CorporationIBM

Price:$231.20-1.25%

P/E 20.39×· 5Y range 11.61–107.57×· bottom 20% of history

Sector: Technology · Industry: Information Technology Services

AnalystsBuy31 analysts
Mkt Cap 217.82BP/E 20.3Div Yield 2.88%ROE 31.1%Earnings in 5d
Low 11.6×20.4×High 107.6×

P/E 20.4× sits at the 20th percentile of its 5.0978781656399725-year history.

Cash $8.13BNet debt $57.14BDebt $65.27B

Cash covers 12% of debt · Q2 2026.

Profilev72g58p77h47q85m63

PMP Verdict

Mixed fundamentals, cheap valuation

Strengths

  • Quality85
  • Profitability77

Risks

  • Financial Health47
Revenue +4.2% CAGRP/E 20× · 20th pctl

Mixed business trading cheap — priced for skepticism.

Bull Case

  • ✓ROE 31.1% — efficient capital deployment
  • ✓P/E 20.4× at bottom 20% of 5-year history

What's happening with IBM

Can Slightly Higher Consulting Revenues Aid IBM's Q3 Earnings? — Yahoo, 10h agoEarnings in 5 daysLast big move: +5.3% on 2026-10-01

Profile

Valuation — 72/100 (Moderate) P/E vs own history: 20th pct → 20/25 FCF yield: 6.3% → 20/25 P/S: 3.2x → 20/25 EV/EBIT: 23.7x → 12/25Valuation72Growth — 58/100 (Moderate) Revenue CAGR: 4.2% → 6/25 Net income CAGR: 16.5% → 20/25 EPS CAGR 5Y: 15.2% → 20/25 Fwd implied growth: 13.4% → 12/25Growth58Profitability — 77/100 (Strong) ROIC: 10.0% → 12/25 ROE: 31.1% → 25/25 Net margin: 15.5% → 20/25 Operating margin: 16.8% → 20/25Profitability77Financial Health — 47/100 (Weak) Altman Z: 2.84 → 18/25 Current ratio: 0.79 → 6/25 Interest coverage: 5.3x → 18/25 Net cash / debt: D/A 38% → 5/25Health47Quality — 85/100 (Strong) Piotroski F: 6/9 → 15/25 Beneish M: -2.49 → 20/25 FCF conversion: 129% → 25/25 Margin stability: σ 3.7% → 25/25Quality85Moat — 63/100 (Moderate) ROIC >12% years: 3/9 yrs → 6/25 Median gross margin: 54.0% → 20/25 FCF-positive years: 9/9 yrs → 25/25 Worst-year net margin: worst 2.7% → 12/25Moat63

Strong earnings quality and profitability; financial health lags behind.

How is each axis scored?
  • Valuation72/100 · Moderate
    • P/E vs own history (20th pct)20/25
    • FCF yield (6.3%)20/25
    • P/S (3.2x)20/25
    • EV/EBIT (23.7x)12/25
  • Growth58/100 · Moderate
    • Revenue CAGR (4.2%)6/25
    • Net income CAGR (16.5%)20/25
    • EPS CAGR 5Y (15.2%)20/25
    • Fwd implied growth (13.4%)12/25
  • Profitability77/100 · Strong
    • ROIC (10.0%)12/25
    • ROE (31.1%)25/25
    • Net margin (15.5%)20/25
    • Operating margin (16.8%)20/25
  • Financial Health47/100 · Weak
    • Altman Z (2.84)18/25
    • Current ratio (0.79)6/25
    • Interest coverage (5.3x)18/25
    • Net cash / debt (D/A 38%)5/25
  • Quality85/100 · Strong
    • Piotroski F (6/9)15/25
    • Beneish M (-2.49)20/25
    • FCF conversion (129%)25/25
    • Margin stability (σ 3.7%)25/25
  • Moat63/100 · Moderate
    • ROIC >12% years (3/9 yrs)6/25
    • Median gross margin (54.0%)20/25
    • FCF-positive years (9/9 yrs)25/25
    • Worst-year net margin (worst 2.7%)12/25

About International Business Machines Corporation

Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world. Show more

It provides software, IT consulting services, and hardware to help business customers modernize their technology workflows. IBM operates in 175 countries and employs approximately 300,000 people. The company has a robust roster of business partners to service its clients, which includes 95% of all Fortune 500 companies. IBM's products, including Red Hat, watsonx, and mainframes, handle some of the world's most important data workloads in areas like finance and retail.

Headquarters: ARMONK, NY · Employees: 287,000 · Website ↗

Price History

Weekly Candlestick Chart — up to 5Y

Key Metrics

Financial snapshot · Tap any metric for its definition and grade

TTM Snapshot

trailing twelve months · YoY
Revenue
69.1B+8%
Op. Income
11.6B+86%
Net Income
10.7B+84%
EPS
11.3+83%
Operating CF
14.9B+12%
Free CF
13.8B+13%

Valuation

72B+
P/E (TTM)20.3xB

Grade B: FairPrice / TTM EPS (own statements) — vs own 5Y history: 11.6x–107.6x · 20th pct

P/FCF16.6xB

Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative

FCF Yield6.3%A

Grade A: ValueTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 4.1%–11.4% · 43rd pct

P/S (TTM)3.15xB

Grade B: FairPrice / TTM Revenue (own statements) — vs own 5Y history: 1.4x–4.6x · 64th pct

EV/EBIT23.7xC

Grade C: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 15.4x–110.9x · 19th pct

EV/Sales4.0xB

Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple

Forward P/E17.9xB

Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth

P/B Ratio6.31xC

Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks

PEG Ratio2.41C

Grade C: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)

Dividend Yield2.88%A

Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress

Payout Ratio58.8%A

Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable

P/E vs own 5Y historyBelow average · 20th pct

Profitability

77B+
ROIC10.0%C

Grade C: AverageNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat

ROE31.1%A

Grade A: StrongReturn on Equity. Neg. equity = heavy buybacks

ROA7.1%C

Grade C: AverageReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit

Net Margin15.5%A

Grade A: HighNet Income / Revenue

Operating Margin16.8%C

Grade C: AverageTTM EBIT / TTM Revenue

Gross Margin58.1%A

Grade A: PremiumGross Profit / Revenue

FCF Margin20.0%A

Grade A: HighFCF / Revenue

True FCF Margin17.2%A

Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost

Growth

58C
Revenue CAGR4.2%D

Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)

Net Income CAGR16.5%A

Grade A: HighCompound annual net income growth (up to 5Y depending on data availability)

EPS CAGR (5Y)15.2%A

Grade A: HighCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0

Implied EPS Growth13.4%B

Grade B: LowAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth

Dilution (5Y)+4.3%C

Grade C: DilutiveShare count change over 5Y

SBC / Net Income17.5%C

Grade C: MedStock-based comp/Net income. >30% = dilution risk

SBC / Revenue2.7%A

Grade A: LowTTM stock-based comp / TTM Revenue

Financial Health

47D+
Altman Z-Score2.84C

Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress

Current Ratio0.79xD

Grade D: LowCurrent Assets/Liabilities

Quick Ratio0.65xC

Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory

Interest Coverage5.3xC

Grade C: OkEBIT/Interest. >10 Strong

Debt Repayment4.1yC

Grade C: AverageYears to repay net debt via FCF

Net Debt/EBIT4.9xD

Grade D: HighLeverage. <2x Low, >4x High

Debt/Equity1.89xC

Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.

Cash / Debt0.12xD

Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash

Quality

85A
Piotroski F-Score6/9C

Grade C: AverageFinancial strength 0–9. >7 Strong

Beneish M-Score-2.49A

Grade A: SafeEarnings manipulation risk. < -2.22 Safe

FCF Conversion128.6%A

Grade A: StrongFCF / Net Income

Margin Stability3.7%A

Grade A: StableEBIT margin std deviation. Lower = stable

Capex / Revenue1.6%A

Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business

Asset Turnover0.46xD

Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales

Insider Transactions

SEC Form 4 · 8 records
Open-market · 90dBuy —Sell $5.8M (1)Other filings 13Net open-market selling

P/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.

Recent insider transactions
Trade dateTransactionShares
Brown Marianne Catherine
Filed
Grant / award
+415
Miebach Michael
Filed
Grant / award
+415
HOWARD MICHELLE J
Filed
Grant / award
+291
Pollack Martha E
Filed
Grant / award
+268
Buberl Thomas
Filed
Grant / award
+444
Show 3 more filings
Additional recent insider transactions
Trade dateTransactionShares
MCNABB FREDERICK WILLIAM III
Filed
Grant / award
+415
Laguarta Ramon
Filed
Grant / award
+415
VOSER PETER R.
Filed
Grant / award
+455
More metrics — Moat, Per Share, Balance Sheet, Market

Moat

63B
ROIC >12% Years3/9 yrsD

Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability

Gross Margin (Med.)54.0%A

Grade A: DurableMedian annual gross margin across available fiscal years — pricing-power durability

FCF-Positive Years9/9 yrsA

Grade A: DurableShare of completed fiscal years with positive free cash flow

Net Margin Floor2.7%C

Grade C: ModerateWeakest annual net margin across completed fiscal years — recession/downcycle resilience

Per Share

EPS (TTM)$11.38

Own TTM net income / shares — same earnings basis as P/E

Cash / Share$8.65

Cash & short-term investments per share (Finnhub)

Book Value / Share$36.65

Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks

Balance Sheet

Total Debt$65.27B

Total debt obligations (short + long term)

Cash & Equiv.$8.13B

Cash and short-term investments

Net Debt$57.14B

Total Debt minus Cash. Negative = Net Cash position

Total Equity$34.54B

Shareholders' equity (book value)

Asset / Liability1.29xC

Grade C: AdequateTotal Assets / Total Liabilities

Market

Market Cap$217.82B

Current Market Capitalization

Beta0.79B

Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings

How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.

Financials as of Jun 2026 · Ratio snapshot Oct 16, 2026

Key Insights: International Business Machines Corporation (IBM)

IBM is down 1.25% in after-hours trading. Piotroski F-Score of 6/9 indicates mixed fundamentals for International Business Machines Corporation. Altman Z-Score of 2.84 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out. Beneish M-Score of -2.49 suggests a low likelihood of earnings manipulation. International Business Machines Corporation converts about 20% of revenue into free cash flow — strong cash generation.

  • Takes ~4.1 years to repay net debt from free cash flow.
  • At a valuation score of 72/100, IBM trades near the cheapest end of its own historical range (P/E 20.3).
  • Return on equity of 31.1% is well above the market average.
  • The stock currently yields 2.9% in dividends.
  • International Business Machines Corporation reports earnings in 5 days — a potential volatility catalyst.

See how IBM ranks on the Capex Tracker — top 50 capital spenders compared.

Next Earnings

DateTimeEPS Est.Rev Est.
Oct 21, 2026After-Hrs$2.90$17.0B

Recent Market Moves

See all IBM moves →
DateSessionPriceMoveZ-Score
Oct 1Pre-market231.66+5.33%2.58

Frequently Asked Questions about IBM

What is the current International Business Machines Corporation (IBM) stock price?

IBM is trading at $231.20 in after-hours trading, down 1.25% on the session. PreMarketPrice tracks IBM pre-market, intraday and after-hours prices.

Is IBM stock a buy right now?

PreMarketPrice's quantitative model rates International Business Machines Corporation's financial health at 47/100. This is a data-driven snapshot of fundamentals, not investment advice.

Is IBM stock overvalued?

International Business Machines Corporation trades at a trailing P/E of 20.3 and our valuation score rates it 72/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.

When does International Business Machines Corporation report earnings?

IBM is scheduled to report on 2026-10-21 (in 5 days). Check the Earnings section for recent results and the full calendar.

What sector does International Business Machines Corporation operate in?

International Business Machines Corporation operates in the Technology sector, within the Information Technology Services industry. The Related Stocks section lists sector peers for comparison.

What does International Business Machines Corporation do?

Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world.

About International Business Machines Corporation (IBM) Stock

International Business Machines Corporation (IBM) is a US-listed stock operating in the Technology sector, specifically the Information Technology Services industry. As of the latest update, International Business Machines Corporation is trading at $231.20, down 1.25% on the day with a market capitalization of $217.8 billion. The financial health score for IBM is 47/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for IBM stock.

IBM Stock Analysis & Key Metrics

On PreMarketPrice, you can track International Business Machines Corporation (IBM) across multiple dimensions:

Is IBM a Good Stock to Buy?

This page provides data-driven analysis to help you evaluate International Business Machines Corporation (IBM) as an investment. The financial health score of 47/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average. Earnings data reveals whether the company is meeting or beating analyst expectations.However, this is not financial advice — always do your own research before investing.

Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.International Business Machines Corporation (IBM) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.

Related opportunities

Moving today in Technology
Cheaper alternatives
Similar fundamentals